Serum Mac‐2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virus
Journal of Gastroenterology and Hepatology · 2024
DOI: 10.1111/jgh.16680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Yu-Ping Chang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Sustained Virologic Response, Antigens, Neoplasm, Antiviral Agents, Liver Cirrhosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Taiwan University Hospital.
Abstract (Originalsprache)
Background and Aim Understanding the dynamics of serum Mac‐2 binding protein glycosylation isomer (M2BPGi) remains pivotal for hepatitis C virus (HCV) patients' post‐sustained virologic response (SVR 12 ) through direct‐acting antivirals (DAAs).
Methods
We compared areas under receiver operating characteristic curves (AUROCs) of M2BPGi, FIB‐4, and APRI and assess M2BPGi cutoff levels in predicting fibrosis stages of ≥F3 and F4 utilizing transient elastography in 638 patients. Variations in M2BPGi levels from pretreatment to SVR 12 and their association with pretreatment alanine transaminase (ALT) levels and fibrosis stage were investigated.
Results
The AUROCs of M2BPGi were comparable to FIB‐4 in predicting ≥F3 (0.914 vs 0.902, P = 0.48) and F4 (0.947 vs 0.915, P = 0.05) but were superior to APRI in predicting ≥F3 (0.914 vs 0.851, P = 0.001) and F4 (0.947 vs 0.857, P < 0.001). Using M2BPGi cutoff values of 2.83 and 3.98, fibrosis stages of ≥F3 and F4 were confirmed with a positive likelihood ratio ≥10. The median M2BPGi change was −0.55. Patients with ALT levels ≥5 times ULN or ≥F3 demonstrated more pronounced median decreases in M2BPGi level compared to those with ALT levels 2–5 times ULN and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
- Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.
- Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
ORCID-Profile: Chen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, Pei-Jer Chen, Jia-Horng Kao
Förderung
- National Taiwan University Hospital
Zitieren
APA
Chang, Y. P., Liu, C. H., Huang, C. B., Lee, J. Y., Liu, C. J., Su, T. H., Huang, S. C., Tseng, T. C., Chen, P. J., & Kao, J. H. (2024). Serum Mac‐2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virus. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16680
Vancouver
Chang YP, Liu CH, Huang CB, Lee JY, Liu CJ, Su TH, et al. Serum Mac‐2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virus. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16680
BibTeX
@article{Chang2024,
author = {Chang, Yu-Ping and Liu, Chen-Hua and Huang, Chiuan-Bo and Lee, Ji-Yuh and Liu, Chun-Jen and Su, Tung-Hung and Huang, Shang-Chin and Tseng, Tai-Chung and Chen, Pei-Jer and Kao, Jia-Horng},
title = {Serum Mac‐2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virus},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
doi = {10.1111/jgh.16680}
}
EUVIMED